Business Description
Level Biotechnology Inc
ISIN : TW0003118006
Total Employee Number:
128Description
Level Biotechnology Inc is a Taiwan-based company engaged in the sales of biomedical products and providing preclinical testing services. The company has three reportable segments: Department A and B, Department C, and Department D. Department A and Department B sell the cell culture consumables and the antibody reagents, Department C sells the instruments and equipment, and Department D provides CRO services. The majority of revenue is derived from the Department A and B.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 26.36 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.07 | |||||
Interest Coverage | 417.59 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 3.82 | |||||
Beneish M-Score | -1.91 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.5 | |||||
3-Year EBITDA Growth Rate | 8.9 | |||||
3-Year EPS without NRI Growth Rate | 10.9 | |||||
3-Year FCF Growth Rate | -22.7 | |||||
3-Year Book Growth Rate | 2.3 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 36.24 | |||||
9-Day RSI | 43.19 | |||||
14-Day RSI | 43.59 | |||||
3-1 Month Momentum % | -5.82 | |||||
6-1 Month Momentum % | -4.68 | |||||
12-1 Month Momentum % | -1.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.82 | |||||
Quick Ratio | 1.4 | |||||
Cash Ratio | 0.77 | |||||
Days Inventory | 74.61 | |||||
Days Sales Outstanding | 65.4 | |||||
Days Payable | 36.93 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 6.93 | |||||
Dividend Payout Ratio | 0.74 | |||||
3-Year Dividend Growth Rate | -1.8 | |||||
Forward Dividend Yield % | 6.93 | |||||
5-Year Yield-on-Cost % | 8.84 | |||||
Shareholder Yield % | 7.35 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 34.99 | |||||
Operating Margin % | 11.34 | |||||
Net Margin % | 10.82 | |||||
EBITDA Margin % | 16.32 | |||||
FCF Margin % | 3.66 | |||||
OCF Margin % | 8.09 | |||||
ROE % | 14.14 | |||||
ROA % | 9.56 | |||||
ROIC % | 13.16 | |||||
3-Year ROIIC % | 6.82 | |||||
ROC (Joel Greenblatt) % | 30.11 | |||||
ROCE % | 16.96 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 13.01 | |||||
PE Ratio without NRI | 13.02 | |||||
Shiller PE Ratio | 14.43 | |||||
Price-to-Owner-Earnings | 78.01 | |||||
PEG Ratio | 3.62 | |||||
PS Ratio | 1.41 | |||||
PB Ratio | 1.78 | |||||
Price-to-Tangible-Book | 1.78 | |||||
Price-to-Free-Cash-Flow | 38.67 | |||||
Price-to-Operating-Cash-Flow | 17.44 | |||||
EV-to-EBIT | 8.47 | |||||
EV-to-EBITDA | 6.89 | |||||
EV-to-Revenue | 1.12 | |||||
EV-to-FCF | 30.74 | |||||
Price-to-GF-Value | 0.89 | |||||
Price-to-Projected-FCF | 1.19 | |||||
Price-to-Median-PS-Value | 0.92 | |||||
Price-to-Graham-Number | 1.01 | |||||
| Price-to-Net-Current-Asset-Value | 4.83 | |||||
Earnings Yield (Greenblatt) % | 11.81 | |||||
FCF Yield % | 2.61 | |||||
Forward Rate of Return (Yacktman) % | 5.02 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Level Biotechnology Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 736.593 | ||
| EPS (TTM) (NT$) | 2.44 | ||
| Beta | 0.0543 | ||
| 3-Year Sharpe Ratio | -0.19 | ||
| 3-Year Sortino Ratio | -0.25 | ||
| Volatility % | 4.4 | ||
| 14-Day RSI | 43.59 | ||
| 14-Day ATR (NT$) | 0.37771 | ||
| 20-Day SMA (NT$) | 31.825 | ||
| 12-1 Month Momentum % | -1.41 | ||
| 52-Week Range (NT$) | 30.85 - 34.7 | ||
| Shares Outstanding (Mil) | 32.45 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Level Biotechnology Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Level Biotechnology Inc Stock Events
| Event | Date | Price (NT$) | ||
|---|---|---|---|---|
| TWD 2.200000 Cash Dividend | 2026-06-10 | 33.70 (-0.15%) | ||
| TWD 1.800000 Cash Dividend | 2025-06-12 | 34.00 (+0.29%) | ||
| 1.05:1 Stock Split | 2011-08-05 | 36.71 (-0.90%) |
Show
Entries
Level Biotechnology Inc Frequently Asked Questions
What is Level Biotechnology Inc(ROCO:3118)'s stock price today?
The current price of ROCO:3118 is NT$31.75. The 52 week high of ROCO:3118 is NT$34.70 and 52 week low is NT$30.85.
When is next earnings date of Level Biotechnology Inc(ROCO:3118)?
The next earnings date of Level Biotechnology Inc(ROCO:3118) is .
Does Level Biotechnology Inc(ROCO:3118) pay dividends? If so, how much?
The Dividend Yield %  of Level Biotechnology Inc(ROCO:3118) is 6.93% (As of Today), Highest Dividend Payout Ratio of Level Biotechnology Inc(ROCO:3118) was 1.5. The lowest was 0.69. And the median was 0.86. The  Forward Dividend Yield % of Level Biotechnology Inc(ROCO:3118) is 6.93%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Level Biotechnology Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers